Literature DB >> 7565842

Botulinum A toxin for the so-called apraxia of lid opening.

V Lepore1, G Defazio, D Acquistapace, C Melpignano, L Pomes, P Lamberti, P Livrea, E Ferrari.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7565842     DOI： 10.1002/mds.870100425

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  8 in total

Review 1.  Uses of botulinum toxin injection in medicine today.

Authors:  A Münchau; K P Bhatia
Journal:  BMJ       Date:  2000-01-15

Review 2.  Emerging Diagnostic and Therapeutic Strategies for Tauopathies.

Authors:  David Coughlin; David J Irwin
Journal:  Curr Neurol Neurosci Rep       Date:  2017-09       Impact factor: 5.081

3.  Treatment of blepharospasm and Meige's syndrome with abo- and onabotulinumtoxinA: long-term safety and efficacy in daily clinical practice.

Authors:  Angela Jochim; Tobias Meindl; Christoph Huber; Tobias Mantel; Silke Zwirner; Florian Castrop; Bernhard Haslinger
Journal:  J Neurol       Date:  2019-10-19       Impact factor: 4.849

Review 4.  Guidelines for the therapeutic use of botulinum toxin in movement disorders. Italian Study Group for Movement Disorders, Italian Society of Neurology.

Authors:  A Berardelli; G Abbruzzese; L Bertolasi; G Cantarella; F Carella; A Currà; D De Grandis; G DeFazio; G Galardi; P Girlanda; P Livrea; N Modugno; A Priori; G Ruoppolo; L Vacca; M Manfredi
Journal:  Ital J Neurol Sci       Date:  1997-10

5.  Development of a Clinical Rating Scale for the Severity of Apraxia of Eyelid Opening, Either Isolated or Associated with Blepharospasm.

Authors:  Gina Ferrazzano; Antonella Muroni; Antonella Conte; Tommaso Ercoli; Giorgio Tamburini; Giovanni Fabbrini; Alfredo Berardelli; Giovanni Defazio
Journal:  Mov Disord Clin Pract       Date:  2020-09-22

Review 6.  A Review of Treatment Options for Progressive Supranuclear Palsy.

Authors:  Maria Stamelou; Günter Höglinger
Journal:  CNS Drugs       Date:  2016-07       Impact factor: 5.749

Review 7.  Use of Botulinum Neurotoxin in Parkinson's Disease: A Critical Appraisal.

Authors:  Wolfgang H Jost
Journal:  Toxins (Basel)       Date:  2021-01-25       Impact factor: 4.546

8.  Antidepressant-Like Properties of Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson's Disease.

Authors:  Veronica Antipova; Carsten Holzmann; Alexander Hawlitschka; Martin Witt; Andreas Wree
Journal:  Toxins (Basel)       Date:  2021-07-20       Impact factor: 4.546
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.